Health Condition 1: E889- Metabolic disorder, unspecified
Conditions
Interventions
None listed
Sponsors
Dr RajimunnisaBegam Shaik
Eligibility
Inclusion criteria
Inclusion criteria: Patients of age group 20-50 years Patients clinically diagnosed on the basis of Samanaya Madatyaya Lakshanas and on the basis of Criteria of Alcohol Use Disorder according to DSM-V ICD-11(Code 6C40 Z) Patients will be selected randomly irrespective of gender economical educational and marital status Patients who are willing to provide written informed consent with desire to stop the alcohol abuse
Exclusion criteria
Exclusion criteria: Patients with severe Alcohol Use Disorder as per AUDIT scoring more than 31 Highly violent patients and Patients suffering from major psychiatric illnesses like Major depressive disorder Schizophrenia Psychosis and Epileptic disorders Patients with any kind of major systemic illness such as Malignancy Diabetes CVD HIV TB etc Patients withLiver failure Liver Cirrhosis Hepatic necrosis Hepatitis Cerebral degeneration Pregnant ladies and lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AUDIT SCALE, Liver parameters like Liver Function Test and the gamma-glutamyl-transferase test in Alcohol Use Disorder. To evaluate the add-on effect of Mahakalyanaka vati capsules on Sleep, Cognition, depression, and side effect profile of Alcohol use Disorder by ISI, MoCA, HAM-D, UKU side effects rating scale. Timepoint: Baseline,4 weeks, and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the add-on effect of Mahakalyanaka vati capsules on WHOQOL-BREF Timepoint: On baseline 0th day and 60th day | — |
Countries
India
Contacts
Public ContactDr RajimunnisaBegam Shaik
KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya and Medical Research Centre, Belagavi
Outcome results
None listed